200 related articles for article (PubMed ID: 6152370)
21. Relationship of aminotransferases to liver histological status in chronic hepatitis C.
Haber MM; West AB; Haber AD; Reuben A
Am J Gastroenterol; 1995 Aug; 90(8):1250-7. PubMed ID: 7639225
[TBL] [Abstract][Full Text] [Related]
22. [Effect of catergen treatment on the histochemical studies of post-alcohol lesions of the liver in rat].
Ciszewska-Popiołek B; Romanowska-Sarlej J; Rzeszowska G; Patorska-Mach E
Patol Pol; 1982; 33(1-2):71-84. PubMed ID: 6127662
[No Abstract] [Full Text] [Related]
23. Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial.
Colman JC; Morgan MY; Scheuer PJ; Sherlock S
Gut; 1980 Nov; 21(11):965-9. PubMed ID: 6108901
[TBL] [Abstract][Full Text] [Related]
24. Characteristic features of liver disease in Japanese alcoholics.
Sugimoto M; Hatori T; Ito T; Furube M; Abei T
Am J Gastroenterol; 1985 Dec; 80(12):993-7. PubMed ID: 4073006
[TBL] [Abstract][Full Text] [Related]
25. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
Bar-Meir S; Halpern Z; Gutman M; Shpirer Z; Baratz M; Bass D
Gut; 1985 Sep; 26(9):975-9. PubMed ID: 3896964
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
27. [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].
Takahashi A; Sekiya C; Yazaki Y; Ono M; Sato H; Hasebe C; Ishikawa Y; Okuno K; Yamada M; Namiki M
Hokkaido Igaku Zasshi; 1986 May; 61(3):431-6. PubMed ID: 3744290
[TBL] [Abstract][Full Text] [Related]
28. [Biological diagnosis of the type of liver disease in alcoholic patients with abnormal liver function tests].
Naveau S; Montembault S; Balian A; Giraud V; Aubert A; Abella A; Capron F; Chaput JC
Gastroenterol Clin Biol; 1999 Nov; 23(11):1215-24. PubMed ID: 10617832
[TBL] [Abstract][Full Text] [Related]
29. Effect of (+)-cyanidanol-3 on receptor activity of lymphocytes and hepatocytes and on hepatocyte-lymphocyte conjugation in alcoholic liver disease.
Sipos J; Gabor V; Toth Z; Ribiczey P
Int J Tissue React; 1984; 6(2):145-54. PubMed ID: 6203861
[TBL] [Abstract][Full Text] [Related]
30. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
[TBL] [Abstract][Full Text] [Related]
31. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
32. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
Sov Med; 1985; (12):26-30. PubMed ID: 4095626
[No Abstract] [Full Text] [Related]
33. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
34. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of gamma glutamyl transpeptidase and the mean corpuscular volume in chronic hepatitis of alcoholic etiology].
Pasqualetti P; Festuccia V; MacCarone C; Di Lauro G; Casale R
Minerva Med; 1995 Oct; 86(10):395-402. PubMed ID: 8622806
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic relevance of the De Ritis quotient and gamma-glutamyltransferase in alcoholic liver parenchyma damage].
Kilger B; Baumgarten R; Fengler JD; Bartke D
Z Arztl Fortbild (Jena); 1986; 80(10):405-6. PubMed ID: 2875568
[No Abstract] [Full Text] [Related]
37. Persistently normal alanine transaminase levels in chronic C hepatitis: what does it tell us?
Dinçer D; Okten A; Kaymakoglu S; Besisik F; Demir K; Tuncer I; Bozaci M; Turkoglu S; Cevikbas U; Cakaloglu Y
Hepatogastroenterology; 2001; 48(41):1397-400. PubMed ID: 11677973
[TBL] [Abstract][Full Text] [Related]
38. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
[TBL] [Abstract][Full Text] [Related]
39. Effects of ursodeoxycholic acid on serum liver enzymes in patients with hepatitis C virus-related chronic liver disease.
Puoti C; Magrini A; Filippi T; Annovazzi G; Pannullo A
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):151-4. PubMed ID: 7712308
[TBL] [Abstract][Full Text] [Related]
40. [Alcoholic liver diseases and their treatment].
Cacciatore L; Antoniello S; Russo M
Clin Ter; 1989 Nov; 131(4):225-32. PubMed ID: 2480864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
